Microwave ablation (MWA) is becoming an effective therapy for inoperable pulmonary metastases from colorectal cancer (CRC). However, it is unclear whether the primary tumor location affects survival after MWA.
OBJECTIVE:
This study aims to investigate the survival outcomes and prognostic factors of MWA based on different primary origins between colon and rectal cancer.
METHODS:
Patients who underwent MWA for pulmonary metastases from 2014 to 2021 were reviewed. Differences in survival outcomes between colon and rectal cancer were analyzed with the Kaplan-Meier method and log-rank tests. The prognostic factors between groups were then evaluated by univariable and multivariable Cox regression analyses.
RESULTS:
A total of 118 patients with 154 pulmonary metastases from CRC were treated in 140 MWA sessions. Rectal cancer had a higher proportion with seventy (59.32% ) than colon cancer with forty-eight (40.68% ). The average maximum diameter of pulmonary metastases from rectal cancer (1.09 cm) was greater than that of colon cancer (0.89 cm; p = 0.026). The median follow-up was 18.53 months (range 1.10 – 60.63 months). The disease-free survival (DFS) and overall survival (OS) in colon and rectal cancer groups were 25.97 vs 11.90 months (p = 0.405), and 60.63 vs 53.87 months (p = 0.149), respectively. Multivariate analyses showed that only age was an independent prognostic factor in patients with rectal cancer (HR = 3.70, 95% CI: 1.28 – 10.72, p = 0.023), while none in colon cancer.
CONCLUSIONS:
Primary CRC location has no impact on survival for patients with pulmonary metastases after MWA, while a disparate prognostic factor exists between colon and rectal cancer.
BrayF., FerlayJ., SoerjomataramI.et al., Global cancer statistics: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J Clin68(6) (2018), 394–424.
2.
DisibioG., FrenchS.W.Metastatic patterns of cancers: Results from a large autopsy study, Arch Pathol Lab Med.132(6) (2008), 931–9.
3.
MitryE., GuiuB., CosconeaS.et al., Epidemiology, management and prognosis of colorectal cancer with lung metastases: a 30-year population-based study, Gut.59(10) (2010), 1383–8.
4.
PfannschmidtJ., DienemannH., HoffmannH.Surgical resection of pulmonary metastases from colorectal cancer: A systematic review of published series, Ann Thorac Surg.84(1) (2007), 324–38.
5.
TampelliniM., OttoneA., BelliniE.et al., The role of lung metastasis resection in improving outcome of colorectal cancer patients: results from a large retrospective study, Oncologist.17(11) (2012), 1430–8.
6.
FergusonC.D., LuisC.R., SteinkeK.Safety and efficacy of microwave ablation for medically inoperable colorectal pulmonary metastases: Single-center experience, J Med Imaging Radiat Oncol.61(2) (2017), 243–249.
7.
QiH., FanW.Value of ablation therapy in the treatment of lung metastases, Thorac Cancer9(2) (2018), 199–207.
8.
HiyoshiY., MiyamotoY., KiyozumiY.et al., CT-guided percutaneous radiofrequency ablation for lung metastases from colorectal cancer, Int J Clin Oncol.24(3) (2019), 288–295.
9.
Correa-GallegoC., FongY., GonenM.et al., A retrospective comparison of microwave ablation vs. radiofrequency ablation for colorectal cancer hepatic metastases, Ann Surg Oncol.21(13) (2014), 4278–83.
10.
KodamaH., UeshimaE., GaoS.et al., High power microwave ablation of normal swine lung: impact of duration of energy delivery on adverse event and heat sink effects, Int J Hyperthermia34(8) (2018), 1186–1193.
11.
ZhangS., SunK., ZhengR.et al., Cancer incidence and mortality in China, Journal of the National Cancer Center12(1) (2020), 2–11.
12.
YamauchiM., LochheadP., MorikawaT.et al., Colorectal cancer: a tale of two sides or a continuum?Gut.61(6) (2012), 794–7.
13.
PriceT.J., BeekeC., UllahS.et al., Does the primary site of colorectal cancer impact outcomes for patients with metastatic disease?Cancer121(6) (2015), 830–5.
14.
WangK., XuD., YanX.L.et al., The impact of primary tumour location in patients undergoing hepatic resection for colorectal liver metastasis, Eur J Surg Oncol.44(6) (2018), 771–777.
15.
CorsiniE.M., MitchellK.G., CorreaA.et al., MD Anderson Pulmonary Metastasectomy Working Group. Effect of primary colorectal cancer tumor location on survival after pulmonary metastasectomy, J Thorac Cardiovasc Surg.162(1) (2021), 296–305.
16.
SponholzS., OguzhanS., MeseM.et al., The impact of primary tumor location on prognosis after colorectal lung metastasectomy, Int J Colorectal Dis.36(8) (2021), 1731–1737.
17.
DupuyD.E.Image-guided thermal ablation of lung malignancies, Radiology260(3) (2011), 633–55.
18.
YamauchiM., MorikawaT., KuchibaA.et al., Assessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal versus distal colorectum, Gut61(6) (2012), 847–54.
19.
LiL., WuK., LaiH., ZhangB.Clinical application of CT-guided percutaneous microwave ablation for the treatment of lung metastasis from colorectal cancer, Gastroenterol Res Pract.2017 (2017), 9621585.
20.
VenturiniM., CariatiM., MarraP.et al., CIRSE standards of practice on thermal ablation of primary and secondary lung tumours, Cardiovasc Intervent Radiol.43(5) (2020), 667–683.
21.
FilippiadisD.K., BinkertC., PellerinO.et al., Cirse quality assurance document and standards for classification of complications: the cirse classification system, Cardiovasc Intervent Radiol.40(8) (2017), 1141–1146.
22.
BartlettD.L., ChuE.Can metastatic colorectal cancer be cured?Oncology (Williston Park)26(3) (2012), 266–75.
KimH.K., ChoJ.H., LeeH.Y.et al., Pulmonary metastasectomy for colorectal cancer: how many nodules, how many times?World J Gastroenterol.20(20) (2014), 6133–45.
25.
BraceC.L.Radiofrequency and microwave ablation of the liver, lung, kidney, and bone: what are the differences?Curr Probl Diagn Radiol.38(3) (2009), 135–43.
26.
VoglT.J., NaguibN.N., Gruber-RouhT.et al., Microwave ablation therapy: clinical utility in treatment of pulmonary metastases, Radiology261(2) (2011), 643–51.
27.
VoglT.J., EckertR., NaguibN.N.et al., Thermal ablation of colorectal lung metastases: Retrospective comparison among laser-induced thermotherapy, radiofrequency ablation, and microwave ablation, AJR Am J Roentgenol207(6) (2016), 1340–1349.
28.
ChengG., ShiL., QiangW.et al., The safety and efficacy of microwave ablation for the treatment of CRC pulmonary metastases, Int J Hyperthermia34(4) (2018), 486–491.
WolfF.J., GrandD.J., MachanJ.T.et al., Microwave ablation of lung malignancies: effectiveness, CT findings, and safety in 50 patients, Radiology247(3) (2008), 871–9.
31.
LeeH., ChoiD.W., ChoY.B.et al., Recurrence pattern depends on the location of colon cancer in the patients with synchronous colorectal liver metastasis, Ann Surg Oncol21(5) (2014), 1641–6.
32.
HugenN., van de VeldeC.J.H., de WiltJ.H.W. and NagtegaalI.D., Metastatic pattern in colorectal cancer is strongly influenced by histological subtype, Ann Oncol25(3) (2014), 651–657.
33.
ChambersA.F., GroomA.C., MacDonaldI.C.Dissemination and growth of cancer cells in metastatic sites, Nat Rev Cancer2(8) (2002), 563–72.
34.
ArnoldD., LuezaB., DouillardJ.Y.et al., Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trials, Ann Oncol28(8) (2017), 1713–1729.
35.
KamranS.C., ClarkJ.W., ZhengH.et al., Primary tumor sidedness is an independent prognostic marker for survival in metastatic colorectal cancer: Results from a large retrospective cohort with mutational analysis, Cancer Med.17(7) (2018), 2934–42.
36.
MeimarakisG., SpelsbergF., AngeleM.et al., Resection of pulmonary metastases from colon and rectal cancer: factors to predict survival differ regarding to the origin of the primary tumor, Ann Surg Oncol.21(8) (2014), 2563–72.
37.
HuangW.L., ChenY.Y., ChangC.C.et al., Pulmonary metastasectomy for colon and rectal cancer: Prognosis analysis disaggregated by the origin of the primary tumor, Asian J Surg.43(11) (2020), 1069–1073.
ShadyW., PetreE.N., VakianiE.et al., Kras mutation is a marker of worse oncologic outcomes after percutaneous radiofrequency ablation of colorectal liver metastases, Oncotarget8(39) (2017), 66117–66127.
40.
AndreT., ShiuK.K., KimT.W.et al., Pembrolizumab in microsatellite-instability-high advanced colorectal cancer, N Engl J Med.383(23) (2020), 2207–2218.
41.
SilvestriniM.T., InghamE.S., MahakianL.M.et al., Priming is key to effective incorporation of image-guided thermal ablation into immunotherapy protocols, JCI Insight2(6) (2017), e90521.
